Meissner
Manufacturer and service provider focused on single-use systems and filtration technologies for biopharmaceutical and pharmaceutical manufacturing. Activities described in the source content include design and manufacture of single-use biocontainers, mixing and filling assemblies, filtration and membrane products, controlled freeze/thaw platforms, application engineering, performance testing, and vertically integrated manufacturing with cleanroom facilities and R&D laboratories.
Industries
Nr. of Employees
small (1-50)
Meissner
Camarillo, California, United States, North America
Patents
Products
Filtration cartridges and capsules for microfiltration/ultrafiltration
Hollow fiber and cartridge-format filtration products for tangential flow and other filtration applications in bioprocessing.
Single-use biocontainers and container films
Single-use biocontainers produced from high-purity films designed to minimize leachables and support cell culture and bioprocess operations.
Controlled freeze/thaw platforms for bulk drug substance
Systems for controlled freezing, storage, shipping and thawing of bulk drug substance with validated freezing profiles and integrated handling and sampling solutions.
Single-use mixing assemblies (rotary impeller and re-circulation systems)
Mixing assemblies and deployment options for hydration and mixing of buffers and media in single-use containers, with validated performance metrics.
Single-use aseptic filling assemblies
Filling assemblies designed for single-use aseptic filling operations addressing dosing accuracy and sterility assurance.
Filtration cartridges and capsules for microfiltration/ultrafiltration
Hollow fiber and cartridge-format filtration products for tangential flow and other filtration applications in bioprocessing.
Single-use biocontainers and container films
Single-use biocontainers produced from high-purity films designed to minimize leachables and support cell culture and bioprocess operations.
Controlled freeze/thaw platforms for bulk drug substance
Systems for controlled freezing, storage, shipping and thawing of bulk drug substance with validated freezing profiles and integrated handling and sampling solutions.
Single-use mixing assemblies (rotary impeller and re-circulation systems)
Mixing assemblies and deployment options for hydration and mixing of buffers and media in single-use containers, with validated performance metrics.
Single-use aseptic filling assemblies
Filling assemblies designed for single-use aseptic filling operations addressing dosing accuracy and sterility assurance.
Services
Custom design and engineering of single-use assemblies and hybrid systems to meet specific process requirements.
In-house R&D laboratories and technical services for membrane characterization, mixing performance testing, and process development support.
Validation testing for mixing assemblies, filtration devices, and shipping/CCI protocols, including ASTM-based shipping tests and container closure integrity assessments.
Mass manufacture and supply of single-use filtration and container assemblies with cleanroom production and vertically integrated supply chain management.
Custom design and engineering of single-use assemblies and hybrid systems to meet specific process requirements.
In-house R&D laboratories and technical services for membrane characterization, mixing performance testing, and process development support.
Validation testing for mixing assemblies, filtration devices, and shipping/CCI protocols, including ASTM-based shipping tests and container closure integrity assessments.
Mass manufacture and supply of single-use filtration and container assemblies with cleanroom production and vertically integrated supply chain management.
Expertise Areas
- Single-use systems manufacturing
- Filtration and membrane development
- Freeze/thaw platform design for bulk drug substance
- Single-use mixing system engineering
Key Technologies
- Single-use biocontainers
- Ultrafiltration membranes
- Hollow fiber filtration
- Tangential flow filtration (TFF)
News & Updates
Announcement of a new manufacturing facility in Athens, Georgia with planned cleanrooms, laboratories, R&D and office space; project described as an expansion of manufacturing capacity.
Acquisition and expansion of a technology building in Castlebar for use as a European manufacturing site including a substantial cleanroom for single-use system production.
Description of a shift to multi-marker continuum-based membrane characterization and a case study showing improved processing time, recovery and buffer consumption for hollow fiber membranes.
Publication of a 2024 sustainability report addressing material sustainability issues and metrics.
Announcement of a new manufacturing facility in Athens, Georgia with planned cleanrooms, laboratories, R&D and office space; project described as an expansion of manufacturing capacity.
Acquisition and expansion of a technology building in Castlebar for use as a European manufacturing site including a substantial cleanroom for single-use system production.
Description of a shift to multi-marker continuum-based membrane characterization and a case study showing improved processing time, recovery and buffer consumption for hollow fiber membranes.
Publication of a 2024 sustainability report addressing material sustainability issues and metrics.